Roivant Other Stockholder Equity from 2010 to 2025

ROIV Stock  USD 10.38  0.10  0.95%   
Roivant Sciences Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity will likely drop to about 4.5 B in 2025. During the period from 2010 to 2025, Roivant Sciences Other Stockholder Equity regression line of quarterly data had mean square error of 398665.1 T and geometric mean of  3,605,392,837. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2010-12-31
Previous Quarter
6.2 B
Current Value
4.5 B
Quarterly Volatility
B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Roivant Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Roivant Sciences' main balance sheet or income statement drivers, such as Discontinued Operations of 97.9 M, Depreciation And Amortization of 18.8 M or Interest Expense of 42 M, as well as many indicators such as Price To Sales Ratio of 116, Dividend Yield of 6.0E-4 or PTB Ratio of 2.04. Roivant financial statements analysis is a perfect complement when working with Roivant Sciences Valuation or Volatility modules.
  
Check out the analysis of Roivant Sciences Correlation against competitors.
For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.

Latest Roivant Sciences' Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Roivant Sciences over the last few years. It is Roivant Sciences' Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Roivant Sciences' overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Roivant Other Stockholder Equity Regression Statistics

Arithmetic Mean3,721,845,414
Geometric Mean3,605,392,837
Coefficient Of Variation27.99
Mean Deviation858,025,944
Median3,024,172,000
Standard Deviation1,041,736,666
Sample Variance1085215.3T
Range3.2B
R-Value0.81
Mean Square Error398665.1T
R-Squared0.66
Significance0.0001
Slope177,373,958
Total Sum of Squares16278229.2T

Roivant Other Stockholder Equity History

20254.5 B
20246.2 B
20235.4 B
20224.9 B
20214.4 B
20203.7 B
20193.1 B

About Roivant Sciences Financial Statements

Roivant Sciences investors use historical fundamental indicators, such as Roivant Sciences' Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Roivant Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity6.2 B4.5 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Roivant Stock Analysis

When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.